⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
December 15, 2025 Deadline Approaching: Join Class Action Against MoonLake Immunotherapeutics (MLTX) – Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Issues Important Reminder to MoonLake Immunotherapeutics Investors – MLTX
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Moves to SueWallSt For MoonLake Immunotherapeutics Investors That Lost Money
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX
MLTX CLASS ACTION: The MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching; Investors Notified to Contact BFA Law by December 15
accessnewswire.com
MLTX